ACTIVON Co., Ltd.

ACTIVON Co. , Ltd. is a South Korean company that develops and produces innovative cosmetic materials focusing on bio-based ingredients and functional peptides, enhancing both product effectiveness and sustainability in the cosmetics sector. Founded in 2009 in Cheongju-si, South Korea, ACTIVON specializes in creating cosmetic materials, with a focus on bio-based ingredients and functional peptides.

The company has engaged in 1 deal, with its most recent being on March 17, 2025, when it raised KRW 10 billion in Series B funding. This round included investments from Industrial Bank of Korea, Korea Investment Partners, IBK Capital, CL Partners, and KIWOOM Capital. The company is currently valued at KRW 53 billion. The founder's history is not publicly available, nor are there mentions of any changes in business strategy or organization structure.

ACTIVON specializes in the development and production of innovative cosmetic materials designed to enhance the effectiveness and sustainability of cosmetic products. Their core offerings include bio-based ingredients and functional peptides that cater to a diverse range of applications in the cosmetics industry. These products are engineered to address various skin concerns, such as anti-aging, moisturizing, and soothing effects, thereby targeting both manufacturers and end consumers seeking high-performance cosmetic solutions. The company emphasizes sustainability in its product formulations, aligning with its commitment to environmental stewardship.

ACTIVON’s products are distributed across North America, Europe, and Asia, serving a broad client base that includes cosmetic brands, manufacturers, and formulators looking to incorporate effective and eco-friendly ingredients into their product lines. ACTIVON generates revenue through a structured B2B sales model, primarily engaging with cosmetic manufacturers and brands that require specialized ingredients for their formulations. Revenue transactions typically occur through contracts for bulk ingredient sales, with clients ordering specific quantities based on their production needs. The company may also explore partnerships for exclusive ingredient development, enhancing their market presence and client loyalty.

Pricing plans are determined based on the specific product types and quantities ordered, though exact pricing details are proprietary. Flagship products include their advanced peptide formulations and bio-based cosmetic ingredients, which are instrumental in driving client engagement and repeat purchases, further solidifying ACTIVON's position in the global cosmetic materials market. In March 2025, ACTIVON Co. , Ltd.

raised KRW 10 billion in Series B funding, which will be utilized to advance its materials research and development and expand into new markets. The company plans to launch new products that focus on enhancing sustainability and efficacy in cosmetic formulations. Specific expansion targets include increasing their presence in North America, Europe, and Asia by the end of 2025.